Oppenheimer has recently resumed Allogene Therapeutics Inc (ALLO) stock to Outperform rating, as announced on August 8, 2024, according to Finviz. Earlier, on May 31, 2024, Piper Sandler had initiated ...
Allo.xyz, a platform specializing in real-world asset (RWA) tokenization and lending, has secured a landmark $100 million ...
UAE-based Allo.xyz, a platform for real-world asset (RWA) tokenization and lending, has secured a $100 million Bitcoin-backed ...
Addressing the $900 trillion real-world asset opportunity, Allo continues to pioneer tokenization solutions that seamlessly ...
Allo Communications LLC, a Lincoln, Nebraska-based telecommunications company, plans to build a fiber-optic broadband network ...
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of Allogene Therapeutics, ...
ALLO Fiber today announced a fiber broadband project installing a 10 Gigabit network in Flagstaff, AZ. This fiber connection ...
The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for ...
ALLO was founded in 2003, and over the last 21 years has expanded its fiber footprint to reach over one million in population ...
LAKE HAVASU CITY, Ariz., Dec. 23, 2024 /PRNewswire/ -- ALLO Fiber today announced a fiber broadband project installing a 10 Gigabit network in Flagstaff, AZ. This fiber connection will enable ...